Association Between Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio with Global Registry of Acute Coronary Events Risk Score in Acute Myocardial Infarction

Penulis

  • Herick Alvenus Willim Internship Doctor, RS Pupuk Kaltim, Bontang, East Borneo, Indonesia
  • Simon Prayogi Pakpahan Internship Doctor, RS Pupuk Kaltim, Bontang, East Borneo, Indonesia
  • Elnath Suprihatin Internship Doctor, RS Pupuk Kaltim, Bontang, East Borneo, Indonesia
  • Andini Agustyana Internship Doctor, RS Pupuk Kaltim, Bontang, East Borneo, Indonesia
  • Dwisetyo Gusti Arilaksono Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, Jakarta
  • Suhardi Cardiologist, RSUD Taman Husada, Bontang, East Borneo, Indonesia

DOI:

https://doi.org/10.55175/cdk.v48i6.76

Kata Kunci:

AMI, GRACE Risk score, NLR, PLR

Abstrak

Background. The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are novel inflammatory markers in cardiovascular diseases. Global Registry of Acute Coronary Events (GRACE) risk score is a scoring system to predict the risk of mortality in acute coronary syndrome. Objective. To investigate the association between NLR and PLR with GRACE risk score in acute myocardial infarction (AMI) patients. Method. A cross-sectional study using data from medical records of AMI patients. The spectrum of AMI includes ST-segment elevation myocardial infarction (STEMI) or non-STEMI. Data analysis was performed using SPSS 20. Results. A total of 136 patients were included, 72.1% male with mean age 56.1 ± 10.5 years. NLR (p<0.001) and PLR (p<0.001) among GRACE risk score groups were significantly different. Mean NLR in low, intermediate, and high GRACE risk score groups were 3.5 ± 2.4, 6.0 ± 4.8, and 7.9 ± 3.9, respectively. Mean PLR in low, intermediate, and high GRACE risk score groups were 117.2 ± 62.3, 183.7 ± 95.8, and 209.9 ± 83.4, respectively. NLR (r=0.527; p<0.001) and also PLR (r=0.496; p<0.001) was significantly positively correlated with GRACE risk score. Conclusion. NLR and PLR are simple and cost-effective inflammatory markers to predict a GRACE risk score and an additional prognostic tool in AMI.

Latar Belakang. Rasio neutrofil-limfosit (RNL) dan rasio platelet-limfosit (RPL) merupakan petanda inflamasi penyakit kardiovaskular baru. Skor risiko Global Registry of Acute Coronary Events (GRACE) digunakan untuk prediksi risiko mortalitas sindrom koroner akut. Tujuan. Menyelidiki hubungan antara RNL dan RPL dengan skor risiko GRACE pada pasien infark miokard akut (IMA). Metode. Studi potong lintang atas data rekam medis pasien IMA. Spektrum IMA meliputi IMA dengan Elevasi Segmen ST (IMA-EST) dan IMA Non-Elevasi Segmen ST (IMA-NEST). Analisis data menggunakan SPSS 20. Hasil. Sebanyak 136 pasien diteliti, 72,1% laki-laki dengan usia rerata 56,1 ± 10,5 tahun. Terdapat perbedaan signifikan nilai RNL (p<0,001) dan RPL (p<0,001) di antara kelompok skor risiko GRACE. Rerata RNL kelompok skor risiko GRACE rendah, sedang, dan tinggi adalah masing-masing 3,5 ± 2,4; 6,0 ± 4,8; dan 7,9 ± 3,9. Rerata RPL kelompok skor risiko GRACE rendah, sedang, dan tinggi adalah masing-masing 117,2 ± 62,3; 183,7 ± 95,8; dan 209,9 ± 83,4. RNL memiliki korelasi positif signifikan dengan skor risiko GRACE (r=0,527; p<0,001). RPL juga memiliki korelasi positif signifikan dengan skor risiko GRACE (r=0,496; p<0,001). Simpulan. RNL dan RPL merupakan petanda inflamasi sederhana dan hemat biaya yang dapat memprediksi skor risiko GRACE dan memberikan nilai prognostik tambahan pada IMA.

Unduhan

Data unduhan belum tersedia.

Referensi

Roth GA, Huffman MD, Moran AE, Feigin V, Mensah GA, Naghavi M, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015;132:1667-78.

Acet H, Ertas F, Akil MA, Ozyurtlu F, Polat N, Bilik MZ, et al. Relationship between hematologic indices and global registry of acute coronary events risk score in patients with st-segment elevation myocardial infarction. Clinical and Applied Thrombosis/Hemostasis. 2016;22(1):60-8.

Mizuno Y, Jacob RF, Mason RP. Inflammation and the development of atherosclerosis. J Atheroscler Thromb. 2011;18(5):351-8.

Budzianowski J, Pieszko K, Burchardt P, Rzeznizak J, Hiczkiewicz J. The role of hematological indices in patients with acute coronary syndrome. Dis Markers. 2017;2017:3041565.

Balta S, Ozturk C. The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets. 2015;26(7):680-1.

Santos HO, Izidoro LFM. Neutrophil-lymphocyte ratio in cardiovascular disease risk assessment. Int J Cardiovasc Sci. 2018;31(5):532-7.

Kurup R, Patel S. Neutrophils in acute coronary syndrome. EMJ Cardiol. 2017;5(1):79-87.

Angkananard T, Anothaisintawee T, McEvoy M, Attia J, Thakkinstian A. Neutrophil lymphocyte ratio and cardiovascular disease risk: a systematic review and metaanalysis. Biomed Res Int. 2018;2018:2703518.

Nunez J, Minana G, Bodi V, Nunez E, Sanchis J, Husser O, et al. Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011;18(21):3226-33.

Nursidiq AA, Purwaningtyas N, Wasyanto T. Association between neutrophil to lymphocyte ratio and left ventricle global longitudinal strain in acute myocardial infarction. Acta Cardiologica Indonesiana. 2018;4(2):80-7.

Thomas MR, Storey RF. The role of platelets in inflammation. Thromb Haemost. 2015;114(3):449-58.

Li H, Zhou Y, Ma Y, Han S, Zhou L. The prognostic value of the platelet-to-lymphocyte ratio in acute coronary syndrome: a systemic review and meta-analysis. Kardiologia Polska. 2017;75(7):666-73.

Firdous S, Malik U. Clinical application of GRACE risk score in patients with acute coronary syndrome. Ann King Edward Medical University. 2017;23(2).

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. The Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction: fourth universal definition of myocardial infarction (2018). Circulation. 2018;138:e618-51.

Bekler A, Altun B, Gazi E, Temiz A, Barutcu A, Gungor O, et al. Comparison of the GRACE risk score and the TIMI risk index in predicting the extent and severity of coronary artery disease in patients with acute coronary syndrome. Anatol J Cardiol. 2015;15(10):801-6.

Fang L, Moore XL, Dart AM, Wang LM. Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol. 2015;12(3):305-12.

Li W, Liu Q, Tang Y. Platelet to lymphocyte ratio in the prediction of adverse outcomes after acute coronary syndrome: a meta-analysis. Sci Rep. 2017;7:40426.

Chen C, Cong BL, Wang M, Abdullah M, Wang XL, Zhang YH, et al. Neutrophil to lymphocyte ratio as a predictor of myocardial damage and cardiac dysfunction in acute coronary syndrome patients. Integr Med Res. 2018;7(2):192-9.

Zhou D, Wang G, Fan Y, Wan Z, Liu X. Platelet to lymphocyte ratio is associated with the severity of coronary artery disease and clinical outcomes of percutaneous coronary intervention in the Chinese Han population. Exp Ther Med. 2017;13(2):731-8.

Fox KAA, Fitzgerald G, Puymirat E, Huang W, Carruthers K, Simon T, et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ Open 2014;4:e004425.

Oncel RC, Ucar M, Karakas MS, Akdemir B, Yanikoglu A, Gulcan AR, et al. Relation of neutrophil-to-lymphocyte ratio with GRACE risk score to in-hospital cardiac events in patients with ST-segment elevated myocardial infarction. Clin Appl Thromb Hemost. 2015;21(4):383-8.

Zhou D, Fan Y, Wan Z, Wen W, Wang X, Zhou J, et al. Platelet-to-lymphocyte ratio improves the predictive power of GRACE risk score for long-term cardiovascular events in patients with acute coronary syndrome. Cardiology. 2016;134(1):39-46.

Durmus E, Kivrak T, Gerin F, Sunbul M, Sari I, Erdogan O. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictors of heart failure. Arq Bras Cardiol. 2015;105(6):606-13.

Arruda-Olson AM, Reeder GS, Bell MR, Weston SA, Roger VL. Neutrophilia predicts death and heart failure after myocardial infarction: a community based study. Circ Cardiovasc Qual Outcomes. 2009;2(6):656-62.

Mangold A, Alias S, Scherz T, Hofbauer T, Jakowitsch J, Panzenbock A, et al. Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in STelevation acute coronary syndrome are predictors of ST-segment resolution and infarct size. Circ Res. 2015;116(7):1182-92.

Tang TT, Yuan J, Zhu ZF, Zhang WC, Xiao H, Xia N, et al. Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Res Cardiol. 2012;107(1):232.

Shiyovich A, Gilutz H, Plakht Y. White blood cell subtypes are associated with a greater long-term risk of death after acute myocardial infarction. Tex Heart Inst J. 2017;44(3):176-88.

Croce K, Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr Opin Hematol. 2007;14(1):55-61.

Paul GK, Sen B, Bari MA, Rahman Z. Correlation of platelet count and acute ST-elevation myocardial infarction. Mymensingh Med J. 2010;19(3):469-73.

Diterbitkan

2021-06-02

Cara Mengutip

Alvenus Willim, H., Prayogi Pakpahan, S., Suprihatin, E., Agustyana, A., Gusti Arilaksono, D., & Suhardi. (2021). Association Between Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio with Global Registry of Acute Coronary Events Risk Score in Acute Myocardial Infarction. Cermin Dunia Kedokteran, 48(6), 299–302. https://doi.org/10.55175/cdk.v48i6.76

Terbitan

Bagian

Articles